Optimizing the dose-averaged linear energy transfer for the dominant intraprostatic lesions in high-risk localized prostate cancer patients by Bo Zhao, Nobuyuki Kanematsu, Shuri Aoki, Shinichiro Mori, Hideyuki Mizuno, Takamitsu Masuda, Hideyuki Takei, Hitoshi Ishikawa

“…Results: Compared to the conventional plans, the boost plans delivered clinically acceptable dose coverage (D90% and D50%) to the target (PTV2) within 1% differences while significantly increasing the minimum LETd by 16 ∼ 24 keV/μm for the PTVboost (63.9 ± 2.8 vs. 44.0 ± 1.3 keV/μm, p < 0.001). …”
Get full text

Synthetic CT generation from CBCT and MRI using StarGAN in the Pelvic Region by Paritt Wongtrakool, Chanon Puttanawarut, Pimolpun Changkaew, Supakiet Piasanthia, Pareena Earwong, Nauljun Stansook, Suphalak Khachonkham

“…Dosimetric evaluation showed a mean dose difference (DD) within 2% for the planning target volume (PTV) and body, with a gamma passing rate (GPR) > 90% under the 2%/2 mm criteria. …”
Get full text